Panacea Biotec Limited
NSE:PANACEABIO.NS
403.15 (INR) • At close July 31, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,325.3 | 1,634.9 | 1,473.5 | 1,157.2 | 1,364.6 | 1,505 | 1,430.2 | 1,291.9 | 1,258.99 | 1,152 | 1,051.2 | 1,107 | 1,387.23 | 1,558.8 | 2,321.7 | 1,324.5 | 1,611.09 | 1,417.6 | 1,820.2 | 1,327.6 | 1,184.86 | 1,677.4 | 1,251.8 | 1,257.8 | 1,223.46 | 1,103.8 | 1,203.3 | 992.8 |
| Cost of Revenue
| 520.8 | 625.5 | 431.9 | 879.5 | 969.9 | 1,140.8 | 581.9 | 548.6 | 574.8 | 477.8 | 364.5 | 1,109.5 | 1,069.07 | 465.9 | 1,038.8 | 426.3 | 588.81 | 425.1 | 638 | 394.4 | 395.55 | 522.8 | 368.9 | 280.7 | 1,093.59 | 253.4 | 435.4 | 244.7 |
| Gross Profit
| 804.5 | 1,009.4 | 1,041.6 | 277.7 | 394.7 | 364.2 | 848.3 | 743.3 | 684.19 | 674.2 | 686.7 | -2.5 | 318.16 | 1,092.9 | 1,282.9 | 898.2 | 1,022.28 | 992.5 | 1,182.2 | 933.2 | 789.31 | 1,154.6 | 882.9 | 977.1 | 129.87 | 850.4 | 767.9 | 748.1 |
| Gross Profit Ratio
| 0.607 | 0.617 | 0.707 | 0.24 | 0.289 | 0.242 | 0.593 | 0.575 | 0.543 | 0.585 | 0.653 | -0.002 | 0.229 | 0.701 | 0.553 | 0.678 | 0.635 | 0.7 | 0.649 | 0.703 | 0.666 | 0.688 | 0.705 | 0.777 | 0.106 | 0.77 | 0.638 | 0.754 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 328.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 390.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 255.83 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 418.23 | 0 | 0 | 0 | 247.49 | 0 | 0 | 0 | 471.63 | 0 | 0 | 0 | 472.5 | 0 | 0 | 0 | 396.65 | 0 | 0 | 0 | 393.75 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 113.04 | 0 | 0 | 0 | 218.21 | 0 | 0 | 0 | 220.05 | 0 | 0 | 0 | 183.74 | 0 | 0 | 0 | 209.78 | 0 | 0 | 0 | 136.44 | 0 | 0 | 0 |
| SG&A
| 582 | 0 | 0 | 504.9 | 531.27 | 456.8 | 508.7 | 0 | 465.7 | 440.4 | 0 | -2.5 | 691.68 | 0 | 0 | 0 | 656.24 | 0 | 0 | 0 | 606.43 | 1,154.6 | 0 | 0 | 530.19 | 0 | 0 | 0 |
| Other Expenses
| 1,157.5 | 1,019.6 | 1,058.4 | 0 | 0 | 0 | 339.6 | 743.3 | 0 | 139.4 | 686.7 | 0 | 0 | 1,079.8 | 1,282.9 | 898.2 | 0 | 992.5 | 1,182.2 | 933.2 | -108.43 | 0 | 882.9 | 977.1 | 129.85 | 850.4 | 767.9 | 748.1 |
| Operating Expenses
| 1,157.5 | 1,019.6 | 1,058.4 | 504.9 | 543.2 | 456.8 | 848.3 | 743.3 | 886.57 | 595.1 | 686.7 | -2.5 | 687.79 | 1,079.8 | 1,282.9 | 898.2 | 783.26 | 992.5 | 1,182.2 | 933.2 | 611.52 | 1,154.6 | 882.9 | 977.1 | 385.68 | 850.4 | 767.9 | 748.1 |
| Operating Income
| -353 | -10.2 | -16.8 | -227.2 | -148.5 | -92.6 | -128.7 | 383.6 | -99.74 | 354 | -137.3 | -323.3 | -369.63 | 13.1 | -48.8 | -126.1 | -49.6 | 38.4 | 266.3 | 112.1 | 210 | 261.1 | -170.7 | 120.2 | -255.81 | -263.9 | -234 | 352.2 |
| Operating Income Ratio
| -0.266 | -0.006 | -0.011 | -0.196 | -0.109 | -0.062 | -0.09 | 0.297 | -0.079 | 0.307 | -0.131 | -0.292 | -0.266 | 0.008 | -0.021 | -0.095 | -0.031 | 0.027 | 0.146 | 0.084 | 0.177 | 0.156 | -0.136 | 0.096 | -0.209 | -0.239 | -0.194 | 0.355 |
| Total Other Income Expenses Net
| 352.6 | 54 | 64.4 | 56.7 | 127.3 | 76.1 | 50.9 | -253.3 | 281.89 | -129.6 | 370.4 | -188.3 | 16,452.23 | -504.7 | -481.3 | -446.6 | -476.96 | -438.5 | -454.4 | -439.8 | -802.4 | -439.4 | -534 | -357 | 2,128.46 | 174.2 | -751.1 | -663.9 |
| Income Before Tax
| -0.4 | 43.8 | 47.6 | -170.5 | -21.2 | -16.5 | -77.8 | 130.3 | 182.15 | 224.4 | 233.1 | -511.6 | 16,082.6 | -491.6 | -530.1 | -572.7 | -526.56 | -400.1 | -188.1 | -327.7 | -592.4 | -178.3 | -704.7 | -236.8 | 1,872.65 | -89.7 | -985.1 | -311.7 |
| Income Before Tax Ratio
| -0 | 0.027 | 0.032 | -0.147 | -0.016 | -0.011 | -0.054 | 0.101 | 0.145 | 0.195 | 0.222 | -0.462 | 11.593 | -0.315 | -0.228 | -0.432 | -0.327 | -0.282 | -0.103 | -0.247 | -0.5 | -0.106 | -0.563 | -0.188 | 1.531 | -0.081 | -0.819 | -0.314 |
| Income Tax Expense
| 19.5 | -0.6 | 0.5 | -11.7 | -1.3 | 5.5 | 5.1 | 20.5 | 308.9 | 30.7 | 76.1 | 49.8 | 3,707.85 | 0.4 | 0 | 0.8 | 14.87 | 0.4 | 0.9 | 3.4 | 91.5 | 23.1 | 23.5 | 28.3 | 25.97 | 49 | -24.5 | 26.6 |
| Net Income
| -18.9 | 45.2 | 48 | -158 | -16.63 | -22.8 | -82.9 | 109.8 | -121.67 | 193.7 | 157 | -561.4 | 12,374.45 | -492 | -530.1 | -573.5 | -541.86 | -400.5 | -193.3 | -341.3 | -696.77 | -213.2 | -750 | -282.7 | 1,859.27 | -159.4 | -970 | -352.6 |
| Net Income Ratio
| -0.014 | 0.028 | 0.033 | -0.137 | -0.012 | -0.015 | -0.058 | 0.085 | -0.097 | 0.168 | 0.149 | -0.507 | 8.92 | -0.316 | -0.228 | -0.433 | -0.336 | -0.283 | -0.106 | -0.257 | -0.588 | -0.127 | -0.599 | -0.225 | 1.52 | -0.144 | -0.806 | -0.355 |
| EPS
| -0.31 | 0.74 | 0.77 | -2.59 | -0.23 | -0.37 | -1.35 | 1.79 | -2.07 | 3.16 | 2.56 | -9.17 | 202.03 | -8.03 | -8.65 | -9.36 | -8.85 | -6.54 | -3.16 | -5.58 | -11.38 | -3.48 | -12.25 | -4.62 | 30.39 | -2.6 | -15.83 | -5.75 |
| EPS Diluted
| -0.31 | 0.74 | 0.77 | -2.59 | -0.23 | -0.37 | -1.35 | 1.79 | -2.07 | 3.16 | 2.56 | -9.17 | 202.02 | -8.03 | -8.65 | -9.36 | -8.85 | -6.54 | -3.16 | -5.58 | -11.38 | -3.48 | -12.25 | -4.62 | 30.39 | -2.6 | -15.83 | -5.75 |
| EBITDA
| 94.2 | 143.5 | 144.2 | -74.5 | 75.1 | 83.1 | 24.4 | 235.1 | 287.7 | 330.7 | 343.8 | -398.6 | 16,500.7 | 135.2 | 80.5 | 16.8 | 51.78 | 170.4 | 400.8 | 237.3 | -48.9 | 401.4 | -179.1 | 284.8 | -663.8 | 255.7 | -556.4 | 79.2 |
| EBITDA Ratio
| 0.071 | 0.088 | 0.098 | -0.064 | 0.055 | 0.055 | 0.017 | 0.182 | 0.229 | 0.287 | 0.327 | -0.36 | 11.895 | 0.087 | 0.035 | 0.013 | 0.032 | 0.12 | 0.22 | 0.179 | -0.041 | 0.239 | -0.143 | 0.226 | -0.543 | 0.232 | -0.462 | 0.08 |